Key result
A 12-week hybrid cardiac rehabilitation program in patients with durable left ventricular assist devices did not significantly improve the primary endpoint of peak oxygen uptake (11.2 vs 12.2 mL/kg/min, p=0.11).
Why the study?
Patients with durable LVADs frequently remain functionally limited despite technological advances, and hybrid cardiac rehabilitation models have not been evaluated in this population.
Does a 12-week hybrid cardiac rehabilitation program improve peak oxygen uptake in patients with durable left ventricular assist devices?
Does a 12-week hybrid cardiac rehabilitation program improve peak oxygen uptake in patients with durable left ventricular assist devices?
Mean Difference: 1
Absolute Event Rate: 12.2% vs 11.2%
p-value: p=0.11
A hybrid cardiac rehabilitation program is feasible and safe for patients with durable LVADs, significantly improving submaximal exercise capacity and quality of life despite no significant change in peak oxygen uptake.
Purpose Patients with durable left ventricular assist devices (LVADs) frequently remain functionally limited despite technological advances. Cardiac rehabilitation may improve functional status, yet access is limited, and hybrid models have not been evaluated. The REHAB-ASSIST study assessed the clinical outcomes, safety, and feasibility of a hybrid cardiac rehabilitation program in this population. Methods In this prospective multicenter proof-of-concept study, LVAD recipients underwent a 12-week hybrid cardiac rehabilitation program combining supervised and telemedicine-supported home-based sessions. The primary clinical endpoint was change in peak oxygen uptake. Secondary endpoints included 6-minute walk distance and quality of life (Kansas City Cardiomyopathy Questionnaire). Safety and feasibility were assessed as separate prespecified domains. Exploratory analyses were performed at 6 months. Results Fifteen patients were enrolled and thirteen completed the program. Median age was 66 years and 93% were male; all had a HeartMate 3® LVAD. Peak oxygen uptake increased modestly but did not reach statistical significance (11.2 vs 12.2 mL/kg/min, p = 0.11). Statistically significant and clinically meaningful improvements were observed in 6-minute walk distance (444 vs. 492 m, p = 0.028) and Kansas City Cardiomyopathy Questionnaire (75.1 vs. 82.2 points, p = 0.042). Ventilatory oscillations were significantly reduced (38.5% vs. 7.7%, p = 0.045). No severe device-related or exercise-related adverse events occurred during the program. Conclusions In patients with LVADs, a hybrid CR program was feasible, with high center-based adherence and no severe exercise-related adverse events observed, and it was associated with meaningful improvements in 6-minute walk distance and quality of life. These findings suggest that submaximal and patient-centered endpoints may be more appropriate than peak oxygen uptake to evaluate rehabilitation in this population, and require confirmation in randomized trials.
No takes yet. Share an insight, caveat, or question.
González et al. (2026) studied Patients with durable left ventricular assist devices (LVADs) (n=15). Hybrid cardiac rehabilitation program vs. Baseline (pre-intervention) was evaluated on Change in peak oxygen uptake (peak VO2) from baseline to 3 months (MD 1.0 mL/kg/min, p=0.11). A 12-week hybrid cardiac rehabilitation program in patients with durable left ventricular assist devices did not significantly improve the primary endpoint of peak oxygen uptake (11.2 vs 12.2 mL/kg/min, p=0.11).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: